ID

15861

Beschreibung

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE); ODM derived from: https://clinicaltrials.gov/show/NCT02425592

Link

https://clinicaltrials.gov/show/NCT02425592

Stichworte

  1. 16.06.16 16.06.16 -
Hochgeladen am

16. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT02425592

Eligibility Prostate Cancer NCT02425592

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 30-80
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
completed mri fusion prostate biopsy either in the past that demonstrated gleason 6 prostate cancer and are either currently enrolled in active surveillance or are interested in active surveillance, or have completed an mri fusion prostate biopsy at the first visit that demonstrates gleason 6 prostate cancer and are interested in active surveillance
Beschreibung

MRI Ultrasound Fusion Guided Biopsy | Gleason Grading System | Prostate carcinoma | Active surveillance

Datentyp

boolean

Alias
UMLS CUI [1]
C3898501
UMLS CUI [2]
C0332326
UMLS CUI [3]
C0600139
UMLS CUI [4]
C1827061
diagnosed with gleason 6 prostate cancer
Beschreibung

Prostate carcinoma | Gleason Grading System

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0332326
psa <20
Beschreibung

Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201544
<ct3 prostate cancer
Beschreibung

Prostate carcinoma | TNM clinical staging

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C3258246
ability to receive an mri with iv gadolinium contrast
Beschreibung

Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injection | Ability

Datentyp

boolean

Alias
UMLS CUI [1]
C0024485
UMLS CUI [2,1]
C3249258
UMLS CUI [2,2]
C0021494
UMLS CUI [3]
C0085732
life expectancy >10 years (by physician estimate)
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
understanding and willingness to provide consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
english speaking
Beschreibung

Able to speak English Language

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
received treatment for prostate cancer (hormone manipulation, surgery, radiation).
Beschreibung

Therapeutic procedure Prostate carcinoma | Hormone manipulation | Operative Surgical Procedures | Therapeutic radiology procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0600139
UMLS CUI [2]
C0586971
UMLS CUI [3]
C0543467
UMLS CUI [4]
C1522449
known metastatic disease
Beschreibung

Metastatic Neoplasm

Datentyp

boolean

Alias
UMLS CUI [1]
C2939420
high risk prostate cancer by epstein criteria
Beschreibung

Prostate carcinoma High risk of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332167
any gleason 7 or higher prostate cancer on prostate biopsy
Beschreibung

Prostate carcinoma | Gleason Grading System | Biopsy of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0332326
UMLS CUI [3]
C0194804
inability to receive an mri with iv gadolinium contrast
Beschreibung

Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injections | Unable

Datentyp

boolean

Alias
UMLS CUI [1]
C0024485
UMLS CUI [2,1]
C3249258
UMLS CUI [2,2]
C0021494
UMLS CUI [3]
C1299582
life expectancy <10 years
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
unwillingness to undergo monitoring and imaging studies
Beschreibung

Clinical study Monitoring Unwilling | Clinical study Imaging Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C1283169
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0008972
UMLS CUI [2,2]
C0079595
UMLS CUI [2,3]
C0558080
non-english speaking
Beschreibung

Able to speak English Language

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245

Ähnliche Modelle

Eligibility Prostate Cancer NCT02425592

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 30-80
boolean
C0001779 (UMLS CUI [1])
MRI Ultrasound Fusion Guided Biopsy | Gleason Grading System | Prostate carcinoma | Active surveillance
Item
completed mri fusion prostate biopsy either in the past that demonstrated gleason 6 prostate cancer and are either currently enrolled in active surveillance or are interested in active surveillance, or have completed an mri fusion prostate biopsy at the first visit that demonstrates gleason 6 prostate cancer and are interested in active surveillance
boolean
C3898501 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
C0600139 (UMLS CUI [3])
C1827061 (UMLS CUI [4])
Prostate carcinoma | Gleason Grading System
Item
diagnosed with gleason 6 prostate cancer
boolean
C0600139 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
Prostate specific antigen measurement
Item
psa <20
boolean
C0201544 (UMLS CUI [1])
Prostate carcinoma | TNM clinical staging
Item
<ct3 prostate cancer
boolean
C0600139 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injection | Ability
Item
ability to receive an mri with iv gadolinium contrast
boolean
C0024485 (UMLS CUI [1])
C3249258 (UMLS CUI [2,1])
C0021494 (UMLS CUI [2,2])
C0085732 (UMLS CUI [3])
Life Expectancy
Item
life expectancy >10 years (by physician estimate)
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
understanding and willingness to provide consent
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Prostate carcinoma | Hormone manipulation | Operative Surgical Procedures | Therapeutic radiology procedure
Item
received treatment for prostate cancer (hormone manipulation, surgery, radiation).
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0586971 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Metastatic Neoplasm
Item
known metastatic disease
boolean
C2939420 (UMLS CUI [1])
Prostate carcinoma High risk of
Item
high risk prostate cancer by epstein criteria
boolean
C0600139 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
Prostate carcinoma | Gleason Grading System | Biopsy of prostate
Item
any gleason 7 or higher prostate cancer on prostate biopsy
boolean
C0600139 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
C0194804 (UMLS CUI [3])
Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injections | Unable
Item
inability to receive an mri with iv gadolinium contrast
boolean
C0024485 (UMLS CUI [1])
C3249258 (UMLS CUI [2,1])
C0021494 (UMLS CUI [2,2])
C1299582 (UMLS CUI [3])
Life Expectancy
Item
life expectancy <10 years
boolean
C0023671 (UMLS CUI [1])
Clinical study Monitoring Unwilling | Clinical study Imaging Unwilling
Item
unwillingness to undergo monitoring and imaging studies
boolean
C0008972 (UMLS CUI [1,1])
C1283169 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0008972 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Able to speak English Language
Item
non-english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video